Publicaciones (38) Publicaciones de ESTHER SALGUEIRO VAZQUEZ

2022

  1. Retrospective study of apremilast drug survival in psoriasis patients in a daily practice setting: A long-term experience

    Dermatologic Therapy, Vol. 35, Núm. 7

2021

  1. A cross-sectional study of psychotropic drug use in the elderly: Consuming patterns, risk factors and potentially inappropriate use

    European Journal of Hospital Pharmacy, Vol. 28, Núm. 2, pp. 88-93

  2. Seguridad de los fármacos antirreumáticos modificadores de la enfermedad biológicos en la artritis reumatoide

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 1, pp. 15-20

2019

  1. Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs and Classical and Selective Cyclooxygenase-2 Inhibitors: A Meta-analysis of Observational Studies

    Journal of Clinical Pharmacology, Vol. 59, Núm. 1, pp. 55-73

  2. Gastrointestinal safety of coxibs: systematic review and meta-analysis of observational studies on selective inhibitors of cyclo-oxygenase 2

    Fundamental and Clinical Pharmacology, Vol. 33, Núm. 2, pp. 134-147

  3. Medicines under additional monitoring in the European Union

    Farmacia Hospitalaria, Vol. 43, Núm. 1, pp. 19-23

  4. What can we learn from the public's understanding of drug information and safety? A population survey

    International Journal of Pharmacy Practice, Vol. 27, Núm. 1, pp. 96-104

2018

  1. A polypharmacy risk prediction model for elderly patients based on sociodemographic and clinical factors

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 56, Núm. 12, pp. 577-584

  2. Cardiovascular and gastrointestinal safety of selective cyclooxygenase-2 inhibitors: a case/non-case study

    International Journal of Clinical Pharmacy, Vol. 40, Núm. 4, pp. 928-935

  3. The most common STOPP/START criteria in Spain. A review of the literature

    Revista Espanola de Geriatria y Gerontologia, Vol. 53, Núm. 5, pp. 274-278

2017

  1. Medication errors associated with oral administration of methotrexate. Data from spontaneous reporting and medical literature review

    Medicina Clinica, Vol. 148, Núm. 7, pp. 330-332

  2. Risk of bursitis and other injuries and dysfunctions of the shoulder following vaccinations

    Vaccine, Vol. 35, Núm. 37, pp. 4870-4876

  3. Updated 2014 stopp criteria to identify potentially inappropriate prescribing in community-dwelling elderly patients

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 55, Núm. 10, pp. 769-773

2016

  1. Beers versus STOPP criteria in polyharmacy community-dwelling older patients

    Farmacia Hospitalaria, Vol. 40, Núm. 3, pp. 150-164

  2. Inappropriate prescriptions in polypharmacy involving elderly outpatients. Are the STOPP criteria useful?

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 54, Núm. 3, pp. 172-176

  3. Optimización de la información sobre la medicación de personas polimedicadas en atención primaria

    Gaceta Sanitaria, Vol. 30, Núm. 1, pp. 69-72

2015

  1. Spontaneous reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs

    European Review for Medical and Pharmacological Sciences, Vol. 19, Núm. 14, pp. 2732-2737

2014

  1. Letter to the editor: Reporting problems related to medications in Spain. The yonotifco (I report) project, an option for citizens

    International Journal of Clinical Pharmacology and Therapeutics

2013

  1. La notificación directa por los pacientes de reacciones adversas a medicamentos en España

    Farmacia Hospitalaria, Vol. 37, Núm. 1, pp. 65-71

  2. Trends in the pharmacological treatment of osteoporosis in Spain from 2000 to 2008

    Maturitas, Vol. 74, Núm. 1, pp. 74-78